D

Damla Ovek

University of Oslo

ORCID: 0000-0001-5300-8098

Publishes on Protein Structure and Dynamics, Computational Drug Discovery Methods, Bioinformatics and Genomic Networks. 6 papers and 81 citations.

6Publications
81Total Citations
#8in ChIP-seq

Is this you? Claim your profile.

Add your photo, update your bio, and get notified when your ranking changes.

Top publicationsby citations

JASPAR 2026: expansion of transcription factor binding profiles and integration of deep learning models
Damla Ovek, Ieva Rauluševičiūtė, Dina Ruud Aronsen et al.|Nucleic Acids Research|2025
Cited by 37Open Access

JASPAR (https://jaspar.elixir.no/) is an open-access database that has provided high-quality, manually curated, and non-redundant DNA binding profiles for transcription factors (TFs) as position frequency matrices (PFMs) for over 20 years. We expanded the CORE (306 new profiles, 12% increase) and UNVALIDATED (433, 60% increase) collections with new PFMs and updated 13 existing profiles. We updated the TF binding site predictions and genome tracks for eight species. TF binding profile clusters and familial TF binding sites were updated accordingly. We integrate the inMOTIFin software to easily simulate regulatory sequences using JASPAR PFMs. To enrich TFs' annotations, we provide scientific literature-based human TF target information. Notably, this release features a deep learning (DL) collection, providing a paradigm shift in modeling and characterizing TF-DNA interactions with 1259 BPNet models trained on Homo sapiens ENCODE chromatin immunoprecipitation followed by sequencing (ChIP-seq) datasets from 240 TFs and interpreted to reveal predictive motif patterns for the models. The motifs associated with the same TF were clustered to provide a summary of the binding properties, resulting in 240 primary and 113 alternative motif patterns in the DL collection. The JASPAR 2026 collections lay a foundation for future endeavors in genomic research, serving the scientific community in uncovering the mechanisms of gene regulation.

ProInterVal: Validation of Protein–Protein Interfaces through Learned Interface Representations
Damla Ovek, Özlem Keskin, Attila Gürsoy|Journal of Chemical Information and Modeling|2024
Cited by 7Open Access

Proteins are vital components of the biological world and serve a multitude of functions. They interact with other molecules through their interfaces and participate in crucial cellular processes. Disruption of these interactions can have negative effects on organisms, highlighting the importance of studying protein-protein interfaces for developing targeted therapies for diseases. Therefore, the development of a reliable method for investigating protein-protein interactions is of paramount importance. In this work, we present an approach for validating protein-protein interfaces using learned interface representations. The approach involves using a graph-based contrastive autoencoder architecture and a transformer to learn representations of protein-protein interaction interfaces from unlabeled data and then validating them through learned representations with a graph neural network. Our method achieves an accuracy of 0.91 for the test set, outperforming existing GNN-based methods. We demonstrate the effectiveness of our approach on a benchmark data set and show that it provides a promising solution for validating protein-protein interfaces.

SARS-CoV-2 Interactome 3D: A Web interface for 3D visualization and analysis of SARS-CoV-2–human mimicry and interactions
Damla Ovek, Ameer Taweel, Zeynep Abali et al.|Bioinformatics|2021
Cited by 5Open Access

SUMMARY: We present a web-based server for navigating and visualizing possible interactions between SARS-CoV-2 and human host proteins. The interactions are obtained from HMI_Pred which relies on the rationale that virus proteins mimic host proteins. The structural alignment of the viral protein with one side of the human protein-protein interface determines the mimicry. The mimicked human proteins and predicted interactions, and the binding sites are presented. The user can choose one of the 18 SARS-CoV-2 protein structures and visualize the potential 3D complexes it forms with human proteins. The mimicked interface is also provided. The user can superimpose two interacting human proteins in order to see whether they bind to the same site or different sites on the viral protein. The server also tabulates all available mimicked interactions together with their match scores and number of aligned residues. This is the first server listing and cataloging all interactions between SARS-CoV-2 and human protein structures, enabled by our innovative interface mimicry strategy. AVAILABILITY AND IMPLEMENTATION: The server is available at https://interactome.ku.edu.tr/sars/.

Protein–Protein‐Binding Interfaces
Zeynep Abali, Damla Ovek, Simge Senyuz et al.|Unknown|2022
Cited by 0

Proteins accomplish vital functions in many cellular processes through their interactions with other molecules. They can act as structural building blocks or catalysts; they may store and transport different molecules; or they may take part in various signaling pathways and are responsible for phase separation in cells. These are only some of the vast number of actions they may take an important role in. These actions can be accomplished via interactions with other proteins, DNA, RNA, etc. Proteins interact through their binding interfaces on their surfaces. Therefore, understanding the structural and functional properties of the protein-binding interfaces is key to explaining mechanisms of action for proteins. A comprehensive understanding of protein–protein interfaces may enable better characterization of disease-related signaling pathways and efficient drug design. In this chapter, we focus on protein–protein interfaces. We define protein–protein interfaces, explain the computational methods to identify them, and discuss their physicochemical properties. We also introduce some of the current databases and tools that can be used for the identification and analysis of protein–protein interfaces.

Similar Researchers

Coming soon — researchers in similar fields and career stages